Results 251 to 260 of about 1,541,952 (310)
A Budget Impact Model of Treatment of Primary Immune Deficiency with Immune Globulin Subcutaneous (Human), 20% (IgPro20) (Hizentra). [PDF]
Pharmacoecon OpenMallick R, Carlton R.
europepmc +1 more source
PharmacoEconomics, 2009 This article reviews budget-impact analyses (BIAs) published to date in peer-reviewed bio-medical journals with reference to current best practice, and discusses where future research needs to be directed. Published BIAs were identified by conducting a computerized search on PubMed using the search term 'budget impact analysis'.
Ewa Orlewska, Laszlo Gulcsi
openaire +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2014
A budget impact analysis (BIA) is used to assess whether the adoption of a new health technology is affordable, given the resource and budget constraints of the context. Increasingly, BIAs are coming to be viewed as an important-if not essential-part of health technology assessment (HTA).
openaire +3 more sources
A budget impact analysis (BIA) is used to assess whether the adoption of a new health technology is affordable, given the resource and budget constraints of the context. Increasingly, BIAs are coming to be viewed as an important-if not essential-part of health technology assessment (HTA).
openaire +3 more sources